• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Femasys Inc (NQ: FEMY )

    1.210 -0.060 (-4.72%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 139,097
    Open 1.280
    Bid (Size) 1.200 (7)
    Ask (Size) 1.270 (1)
    Prev. Close 1.270
    Today's Range 1.200 - 1.285
    52wk Range 0.2479 - 4.750
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024
    FEMY stock results show that Femasys beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire

    Performance

    YTD
    +19.80%
    +19.80%
    1 Month
    -13.57%
    -13.57%
    3 Month
    +10.00%
    +10.00%
    6 Month
    +16.35%
    +16.35%
    1 Year
    +62.42%
    +62.42%

    More News

    Read More
    Femasys Expands Commercial Management Team with Addition of Experienced New Hires
    From Femasys Inc.
    Via GlobeNewswire
    Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives
    From Femasys Inc.
    Via GlobeNewswire
    FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
    From Femasys Inc.
    Via GlobeNewswire
    Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
    From Femasys Inc.
    Via GlobeNewswire
    Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
    From Femasys Inc.
    Via GlobeNewswire
    First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine
    From Femasys Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer
    From Femasys Inc.
    Via GlobeNewswire
    Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
    From Femasys Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.